Published by Mayo Clinic
Tomorrow’s Cure is a Mayo Clinic podcast that is bringing the future of healthcare to the present. Listen to engaging discussions with researchers, doctors and industry experts who are at the forefront of medical innovations. Learn how technology and innovation are changing the healthcare landscape, and how previously unavailable solutions are now improving or saving lives. Tomorrow’s Cure inspires deep thinking as we explore our healthcare future together.
Listen on Apple PodcastsWhat happens when multiple sclerosis symptoms mask a different condition? In this episode of Mayo Clinic’s Tomorrow’s Cure, hosted by Lindsey Seavert, we explore myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), an autoimmune condition often mistaken for multiple sclerosis (MS). Mayo Clinic neurologist Eoin Flanagan, M.D., B.Ch., and pediatric neurologist Brenda Banwell, M.D., discuss how MOG antibodies define a distinct disease, why early recognition and aggressive treatment of acute attacks are critical, and how MOGAD can present with severe optic neuritis, spinal cord inflammation, and brain involvement such as confusion or seizures. They explain the internationally accepted 2023 diagnostic criteria, which integrate clinical syndromes, MRI findings, and antibody testing while accounting for false positives and changing antibody levels over time. The conversation highlights “vanishing” MRI lesions in MOGAD, patient-driven research, emerging relapse-prevention trials, and therapeutic promise in targeting pathways such as IL-6. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
What if repairing damaged cartilage could be done in a single procedure? Using your own cells and the healing signals they need to recover? In this episode of Tomorrow's Cure, host Lindsey Seavert explores RECLAIM, an innovative regenerative medicine approach that combines a patient's own cartilage cells with donor medicinal signaling cells (MSCs) to help repair damaged joints. Joining the conversation are Dr. Daniel Saris and Dr. Mario Hevesi of Mayo Clinic, along with Dr. Christian Lattermann of Mass General Brigham. Together, they discuss why cartilage injuries are so difficult to treat, how RECLAIM works, and why this breakthrough could reshape the future of orthopedic surgery, sports medicine, and joint preservation. The experts also explore the role of stem-cell-inspired therapies, regenerative medicine, hip arthroscopy, knee cartilage repair, and how artificial intelligence may help personalize treatments in the years ahead. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
What if the milk you are drinking could help fight cancer? In this episode of Tomorrow's Cure, we explore cholangiocarcinoma and a surprising new approach to targeting it using milk‑derived nanoparticles and precision aptamer‑based delivery. Host Lindsey Seavert is joined by surgical oncologist Dr. Rory Smoot and long‑term survivor and advocate Melinda Bachini to unpack why this cancer is so challenging, what symptoms and treatment paths patients typically face, and how emerging gene‑delivery platforms and AI‑driven discovery are opening new possibilities when standard therapies fall short. Through Melinda’s 16‑year survivorship story and Dr. Smoot’s lab work that literally starts with skim milk from the Mayo Clinic cafeteria, listeners hear how “chemical antibodies” called aptamers can act as molecular keys to deliver therapy directly to cholangiocarcinoma cells, and how computational tools are accelerating the search for new targets. Together, they discuss the emotional and practical realities of living at the edge of what medicine can do today, the expanding landscape of clinical trials, and why innovation in this rare cancer may ripple out to colon, lung and other hard‑to‑treat tumors. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
This episode will explore how fluorescenceguided surgery is reshaping precision surgery by allowing surgeons to visualize critical anatomy, such as blood flow, bile ducts, and tumors, that was previously invisible. Dr. Polites and Dr. Lautz are interested in discussing current and emerging applications across perfusion assessment, hepatobiliary surgery, and cancer care, including rare and novel use cases that are improving safety and outcomes, particularly in pediatrics. The conversation should also look ahead to how new fluorescent agents and continued innovation position fluorescenceguided surgery as a platform for the future of surgical care. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
What if one of the earliest clues to Alzheimer’s disease could be found during a routine eye exam? In this episode of Tomorrow’s Cure, host Lindsey Seavert sits down with Dr. Oana Dumitrascu, a neurologist at Mayo Clinic, and Dr. Yalin Wang, a researcher at Arizona State University, to explore how retinal imaging and artificial intelligence may help identify signs of Alzheimer’s disease years before symptoms appear. Together, they discuss the science behind “seeing the brain through the eye,” how AI can detect patterns invisible to the human eye, and why earlier detection could transform research, prevention, and patient care. This conversation highlights an exciting intersection of neuroscience, artificial intelligence, and preventive medicine. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
This episode explores why carbon ion therapy is becoming one of the most closely watched developments in radiation oncology. The conversation should connect patient need, the engineering scale behind heavy particle therapy, and the larger research questions now shaping how carbon ions may fit alongside photon and proton therapy in the future. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Award-winning journalist Lindsey Seavert is our new host as we explore the innovations changing the landscape of medicine. Featuring conversations with leading physicians, researchers, and medical experts, the new season looks at everything from AI-powered diagnostics and cutting-edge cancer therapies to surgical technologies improving patient care today.Across a new series of in-depth conversations, we explore the breakthroughs that rarely make headlines and the ways medicine continues to evolve. Becoming smarter, more human, and more connected. Whether you are a patient, clinician, or simply curious about where medicine is headed next, Tomorrow’s Cure delivers accessible, thought-provoking insights wherever you listen to podcasts.How to listen and stay connected:Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Host: Christopher L. Camp, M.D., Creator & Guide | Mayo Clinic Human Optimization Project Guest: Amy Morin, LCSW, Psychotherapist / Mental Strength Coach / International Bestselling Author | Mentally Strong One of the biggest limiters of our mental strength is our very common (usually unintentional) struggle with self-sabotaging behaviors. Since we all feel too busy to do more, maybe the answer is to actually do less? For some behaviors, that is absolutely the case. To help us better understand how we can do less, and be better for it, our expert guest for this episode is bestselling author, Amy Morin. The three big questions she is going to answer for us today are: What exactly is “mental strength?” What are the things we are doing that commonly sabotage our mental strength How can we remove these things from our lives in order to maximize our mental strength? Learn more about the Human Optimization Project at: https://ce.mayo.edu/optimize
Host: Christopher L. Camp, M.D., Creator & Guide | Mayo Clinic Human Optimization Project Guest: Saranya Wyles, M.D., Ph.D., Associate Professor of Dermatology and Regenerative MedicineDirector of Regenerative Dermatology and Skin Longevity LaboratoryMayo Clinic Department of Dermatology, Rochester, MN Your skin is the largest organ in your body, and it does a lot more than just make you look good! It is our primary defense against the outside world and regulates many of our body’s internal functions. Given the major role it plays in our health and overall performance, it is important that we take care of our skin to keep it healthy for as long as possible. Dr. Saryna Wyles is our expert guest here to answer these big questions for us: 1. What does our skin actually do for us and why is skin care so important? 2. How do we make sense of the most common skin care options out there and sort fact from fiction?What are the regular skin care3. practices we should be doing to help us have healthy, vibrant skin life long? Learn more about the Human Optimization Project at: https://ce.mayo.edu/optimize
For people waiting for a lung transplant, every phone call could be life changing. But too many donor lungs are still turned down. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer explores how ex vivo lung perfusion, or EVLP, is helping turn a “no” into a “maybe” and sometimes a “yes” for patients who are running out of options. Cathy talks with Mayo Clinic cardiothoracic surgeon Dr. Jack Haney and Brandi Zofkie, Associate Vice President at Lung Bioengineering, about how EVLP keeps lungs alive outside the body so experts can better evaluate and sometimes improve them before transplant. They discuss real patient impact, the logistics of making this technology available to more centers and the honest challenges that still remain. Listeners will hear why this innovation matters now and what it could mean for the future of lung transplantation, from expanding the donor pool to offering more second chances to breathe. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow • Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow • Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow • Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Chronic lymphocytic leukemia is the most common leukemia in adults, yet its earliest warning sign often hides in plain sight. Monoclonal B cell lymphocytosis, or MBL, affects millions of adults who may never know they carry this precursor to CLL. In this episode of Tomorrow's Cure from Mayo Clinic, host Cathy Wurzer talks with hematologist Dr. Sameer Parikh and researchers Dr. Susan Slager and Dr. Gerald Marti about how MBL was discovered, what it reveals about inherited risk, and why it matters for infections, second cancers and long term health. The conversation explores how large population studies at Mayo Clinic, advanced genomics, and emerging tools like artificial intelligence and liquid biopsy could change when and how CLL is found, monitored and treated. Listeners will also hear candid discussion about ethics, anxiety and watchful waiting, and how Mayo Clinic's PreCure initiative is rethinking cancer prevention clinics for people living with early warning signs in their blood. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow • Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow • Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow • Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
When a child is critically ill and answers are elusive, every day can feel like an eternity. This week on Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with pediatric geneticist Whitney Thompson, M.D., from Mayo Clinic, genomic medicine pioneer Stephen Kingsmore, M.D., DSc, from Rady Children’s Institute for Genomic Medicine, and Sean George, Ph.D., CEO of Inflection Medicine, about how rapid whole genome sequencing is transforming care for the youngest patients. Together, they explore how clinicians are shortening the “diagnostic odyssey,” pairing sequencing with artificial intelligence to identify potential treatments, and redefining what is possible for rare diseases through programs like Mayo Clinic Children’s BabyFORce. You will also hear powerful patient stories, including children whose lives changed after a genomic diagnosis opened the door to targeted therapies, and a candid discussion about cost, access, and ethics as this technology moves toward wider adoption. Tune in to learn how today’s breakthroughs in pediatric genomics could shape the future of medicine for all of us. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow • Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow • Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow • Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Automation is quietly reshaping what happens before, during, and after a medical visit, and for many patients it is almost invisible. In this episode of Tomorrow’s Cure, host Cathy Wurzer talks with Mayo Clinic physician leader Dr. Anjali Bhagra and human centered AI expert Dr. Ravi Bapna about how automation and artificial intelligence are changing the way care teams work, how patients access care, and what it takes to keep people at the center of these advances. They share real stories from clinic and hospital settings, including tools that automatically generate notes from complex visits, systems that help triage patients more quickly around the world, and AI that supports earlier diagnosis. The conversation also tackles the hard questions around trust, bias, and burnout. Listeners will hear how thoughtful automation can free up time for human connection and why the future of healthcare is people and technology working together in new ways. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow • Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow • Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow • Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
For a century, Mayo Clinic Proceedings has captured the evolution of modern medicine, from pioneering cortisone therapy to today’s breakthroughs in artificial intelligence and digital diagnostics. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with Editor in Chief Dr. Karl Nath and hematologist and longtime contributor Dr. Vincent Rajkumar about the journal’s origins, its global influence, and how it helps physicians turn complex science into practical care. They explore innovations such as AI enabled ECGs that can reveal hidden heart rhythm problems, voice biomarkers that may flag cardiovascular disease from a simple speech sample, stem cell approaches for spinal cord injury, and novel therapies that emerged from Mayo Clinic Proceedings and went on to reshape clinical practice.Listen to hear how Mayo Clinic Proceedings is preparing for its second century as a trusted guide to evidence based medicine. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow • Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow • Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow • Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Cardiovascular disease remains the leading cause of death in the United States, yet new science and smarter systems are changing what is possible for patients and families. In this episode of Tomorrow’s Cure, host Cathy Wurzer talks with three leaders who are reshaping how we prevent, understand, and treat heart disease and obesity. Mayo Clinic gastroenterologist Dr. Andres Acosta explains why obesity is not “one size fits all” and how phenotype based, precision treatments can double weight loss success and reduce cardiovascular risk. American Heart Association CEO Nancy Brown explores why heart disease still claims so many lives, how social and economic forces drive risk, and what it will take to improve health for every community. Dr. Kevin Volpp, scientific lead of the AHA Food is Medicine initiative, shares how medically tailored meals and behavioral economics could cut costly hospital readmissions and make healthy eating more affordable. Listen to hear personal stories, practical takeaways, and a hopeful look at the future of heart health. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Rheumatoid arthritis is often seen as “just” joint pain, but Mayo Clinic rheumatologist Dr. John Davis and University of Colorado researcher Dr. Kevin Deane reveal a far more complex and promising story. In this episode of Tomorrow’s Cure, host and journalist Cathy Wurzer explores how autoimmune disease can quietly develop for years before the first swollen joint, and how new blood tests, gut microbiome insights, and the exposome, our lifetime of environmental exposures such as cigarette smoke and wildfire haze, are helping clinicians see risk much earlier. The conversation dives into emerging tools that use artificial intelligence to sift through genetics, autoantibodies, microbiome data, and real-world exposures to predict who is most likely to develop rheumatoid arthritis and who will respond to specific treatments. Hear how prevention trials, lessons from type 1 diabetes, and more virtual models of care could change what it means to live with, or even avoid, rheumatoid arthritis in the future. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Skin is the body’s largest organ, and its health can reveal far more about aging and disease than what shows up in the mirror. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with dermatologist and regenerative medicine expert Dr. Saranya Wyles of Mayo Clinic and biomedical engineer Dr. Adam Feinberg of Carnegie Mellon University about “SkinSpan” and the fast-moving world of 3D bioprinted skin. They explore how layered, living skin models built from human cells and collagen are helping researchers study conditions like eczema, chronic wounds, burns, and age-related changes in skin structure and pigment. The episode also dives into Dr. Feinberg’s hands-on, open-source bioprinting workshops, where clinicians and scientists build their own high-performance bioprinters for a fraction of traditional costs. In turn, democratizing access to advanced regenerative tools and accelerating discovery worldwide. Through these collaborations, bioprinting moves from theory to practice, enabling more teams to test new therapies and customize tissue models for their patients. The conversation further explores “zombie cells” (senescent cells), what they reveal about skin aging and inflammation, and how skin changes may influence whole-body health. Listeners will also hear about the ethical and practical questions that must be answered before bioprinted skin can reach routine patient care. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
In Season 4 of Tomorrow’s Cure, host Cathy Wurzer interviews physicians, scientists, and medical innovators from Mayo Clinic and other leading institutions to explore breakthroughs in health care, medical research, and patient care. From 3D-printed skin and predictive tools for autoimmune disease to patient-centered AI and lifesaving advancements in organ transplantation, this season brings the future of medicine to the present through real stories and real science. Across eight in-depth conversations, we’ll discuss the breakthroughs most of us don’t hear about and the ways medicine is becoming smarter, more human, and more connected. Whether you are a patient, clinician, or simply curious about where medicine is headed next, Tomorrow’s Cure offers accessible, thought-provoking insights anywhere you listen to your podcasts. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
This week’s episode of Tomorrow’s Cure takes you inside the PlatforMed Conference 2025. With over 250 global leaders from healthcare, government, academia, and business, the event explored how platform thinking is transforming the future of clinical care. Get the latest health information from Mayo Clinic's experts, subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc
In this episode of Tomorrow's Cure, we explore brain-computer interfaces (BCIs) - technologies creating direct pathways between the human brain and external devices. These aren't just futuristic concepts. BCIs are already helping paralyzed individuals move prosthetic limbs and control computers with their minds. Join our host Cathy Wurzer in her conversation with Dr. Jonathan J. Parker, Neurosurgeon at Mayo Clinic and Dr. Allen Waziri, Neurosurgeon & Neuroscientist, CEO & co-founder if iCE Neurosystems. Listen to the lively conversation as they explore how this revolutionary technology works, its current applications and future potential as we merge minds with machines. Get the latest health information from Mayo Clinic's experts, subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc
Bring this source into Mato to analyze its transferable patterns and turn them into an original show concept for your audience.
Create a show inspired by this